Unleashing the power of advanced pharmaceutical science, Levamisole HCL, otherwise known as (-)-Tetramisole Hydrochloride, is a superior-quality compound recognized for its exceptional efficacy and broad range of therapeutic benefits. Created from the monohydrochloride component of Levamisole, this compound is esteemed for its extraordinary effectiveness across a multitude of applications within the pharmaceutical industry.
Lauded for its impressive potency and expansive target protein interaction, Levamisole HCL’s distinct mechanism of action qualifies it as an effective therapeutic agent. It thereby offers a potent option for various pharmaceutical applications. Data documenting its LD50 ensures the safe handling and usage of this compound.
Enjoying a revered status in pharmaceutical production, Levamisole HCL is renowned for its immunomodulatory and anthelminthic treatments. A monument to its versatility and efficacy, the wide array of applications for this compound underscores its escalating usage in the medical field.
To ensure safe handling, Levamisole HCL is accompanied by specific precautionary statements. Adherence to these can reduce potential exposure and hazards. For an all-inclusive understanding of safety procedures, consult the compound's GHS classification. Crucially, Levamisole HCL presents minimal ecological risks. Its environmental fate poses no severe risks upon its release into the surroundings. Moreover, its biodegradability provides a safety valve that mitigates environmental impact, making it a preferred choice across several applications.
n